Trial Profile
The role of amylin and glucagon in the management of normalizing glucose excursions in children with type 1 diabetes
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Glucagon (Primary) ; Pramlintide (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacokinetics
- 31 Dec 2005 New trial record.